Complementary & Integrative Healthcare for Children With Autism: A Pilot Study

NCT07458386 — Enrolling by invitation, 20 participants, Life University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

A Complementary and Integrative Healthcare (CIH) Model for Children With Autism Spectrum Disorder-Related Symptoms: A Pilot Observational Study

RegistryNCT07458386, acronym UNK
StatusEnrolling by invitation
Study typeObservational
Enrollment20 (Estimated)
SponsorLife University (Other)
ConditionsAutism Spectrum Disorder
Datesstart 2026-03-16, primary completion 2027-02-01 (estimated), completion 2027-02-01 (estimated), first posted 2026-03-09, last updated 2026-03-20
Locations2 sites in United Kingdom

Related Papers Related Patents Related Grants Related Experts
All trials for Autism Spectrum Disorder

-Summary

To investigate the feasibility of implementing an online assessment battery in tandem with normal \& customary complementary \& integrative healthcare (CIH) provided to children with autism. The secondary aim is to assess the potential impacts of CIH on clinical outcomes.

Expand all sections  ·  Collapse all

+Detailed description

The main aim of this pilot observational study is to investigate the feasibility of implementing an online assessment battery in tandem with normal \& customary, fee-for-service, remotely delivered complementary \& integrative healthcare (CIH, i.e., naturopathy + functional neurological rehabilitation) provided to children with significant parent-reported autism spectrum disorder (ASD)-related symptoms. The primary outcomes are 1) eligibility, 2) compliance, 3) adherence, and 4) retention. A secondary/exploratory aim is to assess the potential clinical impacts of CIH via a validated parent-reported outcome measure (i.e., Autism Treatment \& Evaluation Checklist; ATEC). Data from this study will inform the feasibility of a definitive study powered to assess the effectiveness of CIH care on clinical outcomes in a pediatric population with ASD-related symptoms.

+Arms and interventions

ArmTypeInterventionsDescription
Children (3-12) with ASD-Related SymptomsChildren aged 3-12 years whose parents/caregivers identify the presence of symptoms associated with autism spectrum disorder (ASD; e.g., challenges in communication, social interaction, or repetitive behaviors). A formal clinical diagnosis is not required for inclusion

+Outcome measures

Primary outcomes

  • Proportion of enrollees who are eligible to participate [From enrollment to baseline ATEC submission (up to 48-hours).]: The number of enrollees (i.e., participants who consent) who score >71 on the baseline Autism Treatment \& Evaluation Checklist (ATEC), divided by the total number of enrollees. This assesses 'Eligibility'.
  • Proportion of participants complying with instructions [From enrollment to the end of participation (up to 6-months)]: The number of participants submitting all online ATECs within the 48-hour submission window, divided by the total number of participants. This assesses 'Compliance'.
  • Proportion of participants adhering to recommendations [From enrollment to the end of participation (up to 6-months)]: The number of participants attending ≥90% of scheduled online check-ins with the CIH practitioners, divided by the total number of participants. This assesses 'Adherence'.
  • Proportion of participants retained in the study [From enrollment to the end of the 6-month study period]: The number of participants submitting the 5th and final ATEC, divided by the total number of participants. This assesses 'Retention'.

Secondary outcomes

  • Change in ATEC scores [Baseline; ~1 month; ~3 months; ~4 months; ~6 months]: Change in ATEC scores from baseline. The ATEC is a 77-item parent-report questionnaire encompassing four distinct domains (i.e., speech/language, sociability, sensory/cognitive awareness, \& health/physical/behavior) designed to track the progress of individuals with ASD-related symptoms. Total scores on the ATEC range from 0 to 179 with higher scores indicating greater severity of symptoms.

+Eligibility

Sex: All, ages: 3 Years to 12 Years

Inclusion Criteria:

* 3-12 years of age
* Baseline ATEC score >71

Exclusion Criteria:

\- History of epilepsy

+Locations (2)

FacilityCityCountryStatus
Brain DevelopmentBiddendenUnited Kingdom
The Happy Healthy UnicornMaidstoneUnited Kingdom

+Investigators